Helio Vision
Helio Vision develops a therapy for rare, fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery.
Helio Vision operates in biotechnology, clinical trials, travel based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2016.
The company sits in the biotechnology, clinical trials, travel segment, where it competes on its core product or service.
The business is associated with Greater Boston Area, East Coast, New England, Northeastern US.
It is recorded at the Seed stage.
Recorded headcount: c_00001_00010 employees.
It has disclosed roughly $26K in funding.
| Sector | Biotechnology, Clinical Trials, Travel |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2016 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $259,504 |
Website: www.heliovisioninc.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account